The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Open accessAbstract
Human APOBEC3 enzymes are cellular DNA cytidine deaminases that inhibit and/or mutate a variety of retroviruses, retrotransposons, and DNA viruses. Here, we report a detailed examination of human APOBEC3 gene expression, focusing on APOBEC3G (A3G) and APOBEC3F (A3F), which are potent inhibitors of human immunodeficiency virus type 1 (HIV-1) infection but are suppressed by HIV-1 Vif. A3G and A3F are expressed widely in hematopoietic cell populations, including T cells, B cells, and myeloid cells, as well as in tissues where mRNA levels broadly correlate with the lymphoid cell content (gonadal tissues are exceptions). By measuring mRNA copy numbers, we find that A3G mRNA is ∼10-fold more abundant than A3F mRNA, implying that A3G is the more significant anti-HIV-1 factor in vivo. A3G and A3F levels also vary between donors, and these differences are sustained over 12 months. Responses to T-cell activation or cytokines reveal that A3G and A3F mRNA levels are induced ∼10-fold in macrophages and dendritic cells (DCs) by alpha interferon (IFN-α) and ∼4-fold in naïve CD4 + T cells. However, immunoblotting revealed that A3G protein levels are induced by IFN-α in macrophages and DCs but not in T cells. In contrast, T-cell activation and IFN-γ had a minimal impact on A3G or A3F expression. Finally, we noted that A3A mRNA expression and protein expression are exquisitely sensitive to IFN-α induction in CD4 + T cells, macrophages, and DCs but not to T-cell activation or other cytokines. Given that A3A does not affect HIV-1 infection, these observations imply that this protein may participate in early antiviral innate immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
Chiu, Y.-L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., & Greene, W. C. (2005) · Nature · doi:10.1038/nature03493 · Cited by 439
RetractedIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Self-citationKeele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Self-citationSpecies-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Stopak, K., de Noronha, C., Yonemoto, W., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 732
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 708
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
Self-citationSetting the stage: host invasion by HIV
Hladik, F., & McElrath, M. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2302 · Cited by 564
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
Self-citationMehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., & Gabuzda, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313093200 · Cited by 474
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G
Conticello, S. G., Harris, R. S., & Neuberger, M. S. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.034 · Cited by 469
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons
Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R., & Weitzman, M. D. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.031 · Cited by 389
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., O’Shea, K. S., Moran, J. V., & Cullen, B. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603313103 · Cited by 375
APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition
Muckenfuss, H., Hamdorf, M., Held, U., Perković, M., Löwer, J., Cichutek, K., Flory, E., Schumann, G. G., & Münk, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601716200 · Cited by 356
Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions
Vartanian, J.-P., Guétard, D., Henry, M., & Wain-Hobson, S. (2008) · Science · doi:10.1126/science.1153201 · Cited by 331
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Bishop, K. N., Verma, M., Kim, E.-Y., Wolinsky, S. M., & Malim, M. H. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000231 · Cited by 328
Self-citationDeaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Iwatani, Y., Chan, D. S. B., Wang, F., Stewart-Maynard, K., Sugiura, W., Gronenborn, A. M., Rouzina, I., Williams, M. C., Musier-Forsyth, K., & Levin, J. G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm750 · Cited by 321
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
Self-citationBogerd, H. P., Doehle, B. P., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295
Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination
Bishop, K. N., Holmes, R. K., & Malim, M. H. (2006) · Journal of Virology · doi:10.1128/jvi.00839-06 · Cited by 293
Self-citationPeng, G., Lei, K. J., Jin, W., Greenwell-Wild, T., & Wahl, S. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051512 · Cited by 293
APOBEC-mediated viral restriction: not simply editing?
Holmes, R. K., Malim, M. H., & Bishop, K. N. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.01.004 · Cited by 280
Self-citationAPOBEC proteins and intrinsic resistance to HIV-1 infection
Malim, M. H. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0185 · Cited by 280
Self-citationMbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00272-07 · Cited by 274
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
Bogerd, H. P. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj416 · Cited by 273
Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family
Dang, Y., Wang, X., Esselman, W. J., & Zheng, Y.-H. (2006) · Journal of Virology · doi:10.1128/jvi.01123-06 · Cited by 255
Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain‐Hobson, S., Vartanian, J., et al. (2006) · Hepatology · doi:10.1002/hep.21187 · Cited by 253
Simon, V., Zennou, V., Murray, D., Huang, Y., Ho, D. D., & Bieniasz, P. D. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010006 · Cited by 249
APOBEC-Mediated Editing of Viral RNA
Bishop, K. N., Holmes, R. K., Sheehy, A. M., & Malim, M. H. (2004) · Science · doi:10.1126/science.1100658 · Cited by 247
Self-citationA Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action
Mangeat, B., Turelli, P., Liao, S., & Trono, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400060200 · Cited by 239
Xu, H., Svarovskaia, E. S., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., & Pathak, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400830101 · Cited by 238
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
Doehle, B. P., Schäfer, A., & Cullen, B. R. (2005) · Virology · doi:10.1016/j.virol.2005.06.005 · Cited by 229
Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins
LaRue, R. S., Andrésdóttir, V., Blanchard, Y., Conticello, S. G., Derse, D., Emerman, M., Greene, W. C., Jónsson, S. R., Landau, N. R., Löchelt, M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01976-08 · Cited by 228
Self-citationIdentification of Highly Attenuated Mutants of Simian Immunodeficiency Virus
Desrosiers, R. C., Lifson, J. D., Gibbs, J. S., Czajak, S. C., Howe, A. Y. M., Arthur, L. O., & Johnson, R. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1431-1437.1998 · Cited by 224
Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J., & Yu, X.-F. (2007) · Journal of Virology · doi:10.1128/jvi.02584-06 · Cited by 223
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition
Kinomoto, M., Kanno, T., Shimura, M., Ishizaka, Y., Kojima, A., Kurata, T., Sata, T., & Tokunaga, K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm181 · Cited by 211
Antiretroelement Activity of APOBEC3H Was Lost Twice in Recent Human Evolution
OhAinle, M., Kerns, J. A., Li, M. M. H., Malik, H. S., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.005 · Cited by 204
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., & Wahl, S. M. (2007) · Blood · doi:10.1182/blood-2006-10-051763 · Cited by 202
Guo, F., Cen, S., Niu, M., Saadatmand, J., & Kleiman, L. (2006) · Journal of Virology · doi:10.1128/jvi.01038-06 · Cited by 196
APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS
An, P., Bleiber, G., Duggal, P., Nelson, G., May, M., Mangeat, B., Alobwede, I., Trono, D., Vlahov, D., Donfield, S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11070-11076.2004 · Cited by 193
Type I interferon‐dependent and ‐independent expression of tripartite motif proteins in immune cells
Rajsbaum, R., Stoye, J. P., & O'Garra, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200737916 · Cited by 176
Janini, M., Rogers, M., Birx, D. R., & McCutchan, F. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7973-7986.2001 · Cited by 175
Kieffer, T. L., Kwon, P., Nettles, R. E., Han, Y., Ray, S. C., & Siliciano, R. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1975-1980.2005 · Cited by 172
Chen, K., Huang, J., Zhang, C., Huang, S., Nunnari, G., Wang, F., Tong, X., Gao, L., Nikisher, K., & Zhang, H. (2006) · Journal of Virology · doi:10.1128/jvi.00206-06 · Cited by 161
A macaque model of HIV-1 infection
Hatziioannou, T., Ambrose, Z., Chung, N. P. Y., Piatak, M., Yuan, F., Trubey, C. M., Coalter, V., Kiser, R., Schneider, D., Smedley, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812587106 · Cited by 158
Cytidine deamination induced HIV-1 drug resistance
Mulder, L. C. F., Harari, A., & Simon, V. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710190105 · Cited by 157
Stopak, K., Chiu, Y., Kropp, J., Grant, R. M., & Greene, W. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610138200 · Cited by 152
Liu, B., Sarkis, P. T. N., Luo, K., Yu, Y., & Yu, X.-F. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9579-9587.2005 · Cited by 151
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
Narvaiza, I., Linfesty, D. C., Greener, B. N., Hakata, Y., Pintel, D. J., Logue, E. C., Landau, N. R., & Weitzman, M. D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000439 · Cited by 140
Simon, J. H., Miller, D. L., Fouchier, R. A. M., Soares, M. A., Peden, K., & Malim, M. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1259 · Cited by 140
Self-citationVartanian, J., Meyerhans, A., Sala, M., & Wain–Hobson, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3092 · Cited by 138
Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes
Tanaka, Y., Marusawa, H., Seno, H., Matsumoto, Y. M., Ueda, Y., Kodama, Y., Endo, Y., Yamauchi, J., Matsumoto, T., Takaori‐Kondo, A., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.192 · Cited by 137
Pace, C. S., Keller, J., Nolan, D. A., JAMES, I. R., Gaudieri, S., Moore, C., & Mallal, S. A. (2006) · Journal of Virology · doi:10.1128/jvi.00888-06 · Cited by 132
Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
Jern, P., Russell, R. A., Pathak, V. K., & Coffin, J. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000367 · Cited by 131
APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia
Jin, X., Brooks, A., Chen, H., Bennett, R. P., Reichman, R. C., & Smith, H. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11513-11516.2005 · Cited by 119
Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication
Dang, Y., Siew, L. M., Wang, X., Han, Y., Lampen, R. J., & Zheng, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707586200 · Cited by 114
Schröfelbauer, B., Senger, T., Manning, G., & Landau, N. R. (2006) · Journal of Virology · doi:10.1128/jvi.00388-06 · Cited by 104
STAT1-Independent Cell Type-Specific Regulation of Antiviral APOBEC3G by IFN-α
Sarkis, P. T. N., Ying, S., Xu, R., & Yu, X.-F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4530 · Cited by 103
Alpha Interferon Enhances TRIM5α-Mediated Antiviral Activities in Human and Rhesus Monkey Cells
Sakuma, R., Mael, A. A., & Ikeda, Y. (2007) · Journal of Virology · doi:10.1128/jvi.00419-07 · Cited by 92
Land, A. M., Ball, T. B., Luo, M., Pilon, R., Sandstrom, P. A., Embree, J. E., Wachihi, C., Kimani, J., & Plummer, F. A. (2008) · Journal of Virology · doi:10.1128/jvi.01115-08 · Cited by 91
Biasin, M., Piacentini, L., Caputo, S. L., Kanari, Y., Magri, G., Trabattoni, D., Naddeo, V., Lopalco, L., Clivio, A., Cesana, E., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511988 · Cited by 89
Trapp, S., Derby, N. R., Singer, R., Shaw, A., Williams, V. G., Turville, S. G., Bess, J. W., Lifson, J. D., & Robbiani, M. (2009) · Journal of Virology · doi:10.1128/jvi.00023-08 · Cited by 79 · cited 2×
“We also note that a recent study reported the IFN- -mediated induction of 20-kDa A3G-related peptides in DCs in the absence of mRNA induction (77).”
BackgroundResultDo, H., Vasilescu, A., Diop, G., Thomas Hirtzig, A., Heath, S. C., Coulonges, C., Rappaport, J., Therwath, A., Lathrop, M. G., Matsuda, F., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/426826 · Cited by 79
A New Type of G→A Hypermutation Affecting Human Immunodeficiency Virus
Fitzgibbon, J. E., Mazar, S., & Dubin, D. T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.833 · Cited by 79
Rose, K. M., Marin, M., Kozak, S. L., & Kabat, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406760200 · Cited by 78
Further Investigation of Simian Immunodeficiency Virus Vif Function in Human Cells
Gaddis, N., Sheehy, A. M., Ahmad, K. M., Swanson, C. M., Bishop, K. N., Beer, B., Marx, P. A., Gao, F., Bibollet‐Ruche, F., Hahn, B. H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12041-12046.2004 · Cited by 70
Self-citationPido-Lopez, J., Whittall, T., Wang, Y., Bergmeier, L. A., Babaahmady, K., Singh, M., & Lehner, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1671 · Cited by 68
Cho, S., Drechsler, H., Burke, R. C., Arens, M. Q., Powderly, W. G., & Davidson, N. O. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.2069-2072.2006 · Cited by 67
Regulated Production and Anti-HIV Type 1 Activities of Cytidine Deaminases APOBEC3B, 3F, and 3G
Rose, K. M., Marin, M., Kozak, S. L., & Kabat, D. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.611 · Cited by 60
Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals
An, P., Duggal, P., Wang, L. H., O’Brien, S. J., Donfield, S. M., Goedert, J. J., Phair, J., Buchbinder, S., Kirk, G. D., & Winkler, C. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030019 · Cited by 57
Kijak, G. H., Janini, L. M., Tovanabutra, S., Sanders‐Buell, E., Arroyo, M. A., Robb, M. L., Michael, N. L., Birx, D. L., & McCutchan, F. E. (2008) · Virology · doi:10.1016/j.virol.2008.03.017 · Cited by 54
Valcke, H. S., Bernard, N. F., Bruneau, J., Alary, M., Tsoukas, C. M., & Roger, M. (2006) · AIDS · doi:10.1097/01.aids.0000247124.35129.e1 · Cited by 53
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells
Anderson, J. L., & Hope, T. J. (2008) · Virology · doi:10.1016/j.virol.2008.01.042 · Cited by 51
Ulenga, N. K., Sarr, A. D., Thakore-Meloni, S., Sankalé, J.-L., Eisen, G., & Kanki, P. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/590212 · Cited by 47
T Cells Contain an RNase-Insensitive Inhibitor of APOBEC3G Deaminase Activity
Thielen, B. K., Klein, K. C., Walker, L. W., Rieck, M., Buckner, J. H., Tomblingson, G. W., & Lingappa, J. R. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030135 · Cited by 46
Knoepfel, S. A., Salisch, N. C., Huelsmann, P. M., Rauch, P., Walter, H., & Metzner, K. J. (2008) · Journal of Virology · doi:10.1128/jvi.00554-08 · Cited by 17
Cited by
Evidence for APOBEC3B mutagenesis in multiple human cancers
Burns, M. B., Temiz, N. A., & Harris, R. S. (2013) · Nature Genetics · doi:10.1038/ng.2701 · Cited by 755
HIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
Self-citationThe APOBEC Protein Family: United by Structure, Divergent in Function
Salter, J. D., Bennett, R. P., & Smith, H. C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.001 · Cited by 408
Taylor, B. J., Nik-Zainal, S., Wu, Y. L., Stebbings, L. A., Raine, K., Campbell, P. J., Rada, C., Stratton, M. R., & Neuberger, M. S. (2013) · eLife · doi:10.7554/elife.00534 · Cited by 375
Evolutionary conflicts between viruses and restriction factors shape immunity
Duggal, N. K., & Emerman, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3295 · Cited by 366
Metadata
- Authors
- Koning, F. A., Newman, E. N. C., Kim, E.-Y., Kunstman, K. J., Wolinsky, S. M., & Malim, M. H.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2009-09-15
- Volume
- 83
- Issue
- 18
- Pages
- 9474-9485
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W1997345818
- Cited by
- 336
- References
- 86
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.